FDA expands monkeypox vaccine eligibility to include “high-risk” children… HUH?

(Natural News) The FDA recently expanded its Emergency Use Authorization (EUA) for the monkeypox vaccine, allowing it to be used in children under 18 who are considered to have a “high risk” of infection. Before the updated EUA, “numerous” children had been given the vaccine via a special permission process despite not being authorized … [Read More...]